Target Blood Pressure in Acute Ischemic Stroke
For patients receiving thrombolytic therapy, blood pressure must be lowered to <185/110 mmHg before treatment and maintained <180/105 mmHg for 24 hours afterward; for patients not receiving reperfusion therapy with BP <220/120 mmHg, do not treat the blood pressure acutely.
Blood Pressure Management Based on Thrombolysis Status
Patients Receiving IV Thrombolysis (tPA)
Pre-thrombolysis targets:
- Lower BP to <185/110 mmHg before administering tPA 1, 2, 3
- Use slow, controlled reduction to avoid precipitous drops
- Exclude patients requiring aggressive IV antihypertensive treatment to reach these targets
Post-thrombolysis targets:
- Maintain BP <180/105 mmHg for at least 24 hours after initiating therapy 4, 1, 2, 3
- Monitor BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours 5
- Higher BP during this period increases risk of symptomatic intracranial hemorrhage 2
Recommended agents:
- Labetalol 10-20 mg IV over 1-2 minutes (may repeat once) 5
- Nicardipine IV 5 mg/hr, titrate by 2.5 mg/hr every 5-15 minutes (maximum 15 mg/hr) 5, 6
Patients Receiving Mechanical Thrombectomy
- Apply same BP targets as thrombolysis: <180/105 mmHg before and during the 24 hours post-procedure 4
- Evidence remains limited, but these thresholds reduce reperfusion injury risk 4
Patients NOT Receiving Reperfusion Therapy
BP <220/120 mmHg:
- Do NOT treat blood pressure in the first 48-72 hours 1, 2, 7
- This is a Class III (No Benefit) recommendation with Level A evidence 1, 2
- Permissive hypertension maintains cerebral perfusion when autoregulation is impaired 4, 2
BP ≥220/120 mmHg:
- May cautiously lower BP by approximately 15% over 24 hours 8, 1, 2, 3
- Never reduce by >25% of mean arterial pressure 8, 3
- Avoid precipitous drops that could worsen ischemia 3, 9
Critical Pitfalls to Avoid
Excessive BP lowering is harmful:
- Cerebral autoregulation is impaired in acute stroke—perfusion depends on systemic BP 4, 2
- The INWEST trial showed that lowering diastolic BP ≥20% increased risk of death or dependency 8
- Rapid drops can induce ischemia, particularly with intracranial or extracranial arterial occlusion 3, 10
Avoid aggressive treatment in non-thrombolysis candidates:
- Multiple trials (CATIS, ENOS) showed no benefit and potential harm from acute BP lowering in patients not receiving reperfusion therapy 2
- The U-shaped relationship between BP and outcomes means both extremes are detrimental 11
After the Acute Phase (>72 hours)
For neurologically stable patients with BP >140/90 mmHg:
- Starting or restarting antihypertensives during hospitalization is safe and reasonable 1, 2, 7
- Target BP <140/90 mmHg after the acute phase 3, 10
- Preferred regimen: ACE inhibitor plus thiazide diuretic combination 3, 10
Practical Algorithm
Determine thrombolysis eligibility immediately
- If eligible AND BP >185/110 mmHg → treat to <185/110 before tPA, then maintain <180/105 for 24h
- If eligible AND BP <185/110 mmHg → proceed with tPA, monitor closely
If NOT receiving reperfusion therapy:
- BP <220/120 mmHg → no treatment (permissive hypertension)
- BP ≥220/120 mmHg → cautious 15% reduction over 24h
- Comorbid emergencies (MI, heart failure, aortic dissection) override these thresholds 1
After 72 hours:
- Initiate/restart antihypertensives if BP >140/90 mmHg and patient stable
- Use ACE inhibitor/thiazide combination preferentially
The most recent high-quality evidence from the 2024 ESC Guidelines 4 and 2018 ACC/AHA Guidelines 1, 2 strongly supports this stratified approach, with thrombolysis status as the primary decision point for acute BP management.